Biocon Finished Products - Check the list of finished products by Biocon on the Economic Times Biocon Limited brand List that includes tablets, capsules, syrups, etc.
Find Biocon Ltd. medicine list, buy Biocon Ltd. products online. USD 118.00. It augurs well for this emerging business, which will be one of our growth drivers in the coming years.
We filed the initial set of Abbreviated New Drug Applications (ANDAs) in the US and Marketing Authorization Applications (MAAs) in the EU in FY15. Those products are used for quality control and research purposes at the universities and in many industries like animal production, food processing, oenology, beer, dietary supplements, the detergents, the textile auxiliaries and the leather auxiliariesLider en fabricación y comercialización de enzimas en España The investments in building commercial manufacturing scale for potent / oncology APIs and drug products will enable us to aggressively address global opportunities in the coming years.To offset the growing commoditization in statins, we have been moving towards a more profitable product mix with a better contribution from products like immunosuppressants where we have developed strong capabilities. Biocon was founded in 1978 with ₹ 10,000 (US$140) as the initial capital. Biocon's first product to go to market was papain, an enzyme found in papaya which is used to prevent beer from turning hazy. BIOCON offers an extensive range of Kits and reagents for the analysis of enzymes and substrates. Branded Formulations divisions are diabetology, oncology, nephrology, cardiology, comprehensive care, immunotherapy, bioproducts - Small Molecules (APIs & Generic Formulations)This first Generic Formulations approval in the regulated markets underscores Bioconâs unique strengths in the chronic therapies space and our compliance with global regulatory standards that enable us to achieve the highest quality benchmarks for all our products. Mylan and Biocon Biologic's insulin glargine has received regulatory approval in more than 45 countries around the world and is the third product approved by FDA through the Mylan-Biocon … USD. We are at the service of the industry to collaborate in the development of new products and processes whenever enzymes are needed.BIOCON offers professional customers, distributors, universities and technological centers, an extensive catalogue of concentrate enzymes in small packages, for testing purposes and for special applications. View Detail - 70.00. The recently-acquired oncology API manufacturing facility in Vishakhapatnam will ensure complete vertical integration of potent products. We offer a robust portfolio of more than 7,500 products, including biosimilars, generics, brand, and over-the-counter remedies. We will look at all options including First-to-Files and Para IVs as part of our plans for the Generic Formulations business. Biocon is India's premier biopharma enterprise focused on innovation to deliver affordable healthcare solutions to patients, partners and healthcare systems across the globe. Buy online at discounted prices. Brands listed with corresponding Generic name and price details. Rapacan : Sirolimus 1 mg Tablet 10'S. Biocon continues to be a trusted partner for global pharmaceutical companies, which rely on our complex and difficult-to-make Small Molecule Active Pharmaceutical Ingredients (APIs) for their formulations spanning statins, immunosuppressants, antifungals, anti-obesity, anti-diabetics, ophthalmologicals, oncologicals and urologicals etc. We also bolstered our MAA portfolio in the EU.We have a clear strategy to pursue the Generic Formulations opportunity in both developed as well as emerging markets by utilizing our well-established R&D Capabilities and cGMP compliant manufacturing facilities, including our injectable formulations and fill-finish facilities. To feed our small pipeline and target early-market entry, we are evaluating new molecules. Until 1983, the company blended enzymes and supplied them to brewing, textiles, biofuels, animal feed and other such industries across the world. This is already leading to better earnings quality in the Small Molecule APIs business.A new entity Biocon Pharma Ltd. was established in FY16 to represent the Generic Formulations business. BIOCON offers a wide range of feed enzymes and additives to get the highest yield from compounded feeds in animal production. This year, we made two ANDA filings and also acquired an ANDA dossier for Simvastatin from a third party, adding to our nascent pipeline for the US. We started construction of our first potent oral solid dosage formulations facility in Bangalore during the year to support this business. We supply the specifications sheet, safety data sheet and, at the client request, the method of analysis.BIOCON offers an extensive range of Kits and reagents for the analysis of enzymes and substrates.